These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8542606)
21. Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus. Ikeda R; Matsuyama H; Nishikawa A; Shinoda T; Fukazawa Y Microbiol Immunol; 1991; 35(2):125-38. PubMed ID: 1886490 [TBL] [Abstract][Full Text] [Related]
22. Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter. Fonseca FL; Nohara LL; Cordero RJ; Frases S; Casadevall A; Almeida IC; Nimrichter L; Rodrigues ML Infect Immun; 2010 Sep; 78(9):3861-70. PubMed ID: 20547742 [TBL] [Abstract][Full Text] [Related]
23. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Kozel TR; Levitz SM; Dromer F; Gates MA; Thorkildson P; Janbon G Infect Immun; 2003 May; 71(5):2868-75. PubMed ID: 12704160 [TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen. Percival A; Thorkildson P; Kozel TR Clin Vaccine Immunol; 2011 Aug; 18(8):1292-6. PubMed ID: 21697342 [TBL] [Abstract][Full Text] [Related]
25. Polysaccharide diversity in VNI isolates of Cryptococcus neoformans from Roraima, Northern Brazil. Dal Pupo HD; Sena BAG; Reis FCG; Machado L; Fortes ST; de Almeida Junior JN; Godinho RMC; Rodrigues ML Fungal Biol; 2019 Oct; 123(10):699-708. PubMed ID: 31542188 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of part structures of Cryptococcus neoformans serotype C capsular polysaccharide. Guazzelli L; McCabe O; Oscarson S Carbohydr Res; 2016 Oct; 433():5-13. PubMed ID: 27423877 [TBL] [Abstract][Full Text] [Related]
27. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Nimrichter L; Frases S; Cinelli LP; Viana NB; Nakouzi A; Travassos LR; Casadevall A; Rodrigues ML Eukaryot Cell; 2007 Aug; 6(8):1400-10. PubMed ID: 17573547 [TBL] [Abstract][Full Text] [Related]
28. Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Vaishnav VV; Bacon BE; O'Neill M; Cherniak R Carbohydr Res; 1998 Jan; 306(1-2):315-30. PubMed ID: 9691456 [TBL] [Abstract][Full Text] [Related]
29. Structural investigation of the capsular polysaccharide produced by a novel Klebsiella serotype (SK1). Location of O-acetyl substituents using NMR and MS techniques. Cescutti P; Ravenscroft N; Ng S; Lam Z; Dutton GG Carbohydr Res; 1993 Jun; 244(2):325-40. PubMed ID: 8348556 [TBL] [Abstract][Full Text] [Related]
30. Complete structure of the cell surface polysaccharide of Streptococcus oralis ATCC 10557: a receptor for lectin-mediated interbacterial adherence. Abeygunawardana C; Bush CA; Cisar JO Biochemistry; 1991 Jul; 30(26):6528-40. PubMed ID: 2054351 [TBL] [Abstract][Full Text] [Related]
31. Glucuronoxylomannan of Cryptococcus neoformans serotype D: structural analysis by gas-liquid chromatography-mass spectrometry and by 13C-nuclear magnetic resonance spectroscopy. Cherniak R; Morris LC; Turner SH Carbohydr Res; 1992 Jan; 223():263-9. PubMed ID: 1596924 [No Abstract] [Full Text] [Related]
32. Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. Janbon G; Himmelreich U; Moyrand F; Improvisi L; Dromer F Mol Microbiol; 2001 Oct; 42(2):453-67. PubMed ID: 11703667 [TBL] [Abstract][Full Text] [Related]
33. Glucuronoxylomannan of Cryptococcus neoformans serotype C: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy. Cherniak R; Morris LC; Meyer SA Carbohydr Res; 1992 Mar; 225(2):331-7. PubMed ID: 1643653 [No Abstract] [Full Text] [Related]
35. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D. Ikeda R; Nishikawa A; Shinoda T; Fukazawa Y Microbiol Immunol; 1985; 29(10):981-91. PubMed ID: 3908888 [TBL] [Abstract][Full Text] [Related]
36. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles. Maitta RW; Datta K; Chang Q; Luo RX; Witover B; Subramaniam K; Pirofski LA Infect Immun; 2004 Aug; 72(8):4810-8. PubMed ID: 15271943 [TBL] [Abstract][Full Text] [Related]
37. Structure of the capsular polysaccharide of Clostridium perfringens Hobbs 5 as determined by NMR spectroscopy. Kalelkar S; Glushka J; van Halbeek H; Morris LC; Cherniak R Carbohydr Res; 1997 Apr; 299(3):119-28. PubMed ID: 9163894 [TBL] [Abstract][Full Text] [Related]
38. The cell wall polysaccharide of Streptococcus gordonii 38: structure and immunochemical comparison with the receptor polysaccharides of Streptococcus oralis 34 and Streptococcus mitis J22. Reddy GP; Abeygunawardana C; Bush CA; Cisar JO Glycobiology; 1994 Apr; 4(2):183-92. PubMed ID: 8054717 [TBL] [Abstract][Full Text] [Related]
39. Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties. Ramos CL; Fonseca FL; Rodrigues J; GuimarĂ£es AJ; Cinelli LP; Miranda K; Nimrichter L; Casadevall A; Travassos LR; Rodrigues ML Eukaryot Cell; 2012 Sep; 11(9):1086-94. PubMed ID: 22562469 [TBL] [Abstract][Full Text] [Related]
40. Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans. Liu OW; Kelly MJ; Chow ED; Madhani HD Eukaryot Cell; 2007 Apr; 6(4):630-40. PubMed ID: 17337638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]